Petroleo Brasileiro SA Petrobras
PBR
Strategy
MSTR
Vale SA
VALE
KB Home
KBH
Apple
AAPL
US Stock MarketDetailed Quotes
ESPR Esperion Therapeutics
- 1.860
- -0.010-0.53%
Close Feb 14 16:00 ET
- 1.880
- +0.020+1.07%
Post 19:40 ET
366.49MMarket Cap-2.78P/E (TTM)
1.900High1.820Low1.92MVolume1.830Open1.870Pre Close3.57MTurnover0.98%Turnover RatioLossP/E (Static)197.04MShares3.94052wk High-0.99P/B363.74MFloat Cap1.58052wk Low--Dividend TTM195.56MShs Float120.960Historical High--Div YieldTTM4.28%Amplitude0.700Historical Low1.863Avg Price1Lot Size
About Esperion Therapeutics Company
Esperion Therapeutics, Inc. is a pharmaceutical company, which engages in the development and commercialization of oral therapies for elevated low-density lipoprotein cholesterol. The firm offers NEXLETOL (bempedoic acid) tablets, and NEXLIZET (bempedoic acid and ezetimibe) tablets. The company was founded by Roger S. Newton, Hans Ageland, Jan O. Johansson, Anders Paul Wiklund, Michael E. Pape, David I. Scheer and Charles L. Bisgaier in May 1998 and is headquartered in Ann Arbor, MI.
Company Profile
SymbolESPR
Company NameEsperion Therapeutics
Listing DateJun 26, 2013
Issue Price14.00
Founded1998
CEOMr. Sheldon L. Koenig
MarketNASDAQ
Employees240
Fiscal Year Ends12-31
Address3891 Ranchero Drive,Suite 150
CityAnn Arbor
ProvinceMichigan
CountryUnited States of America
Zip Code48108
Phone1-734-887-3903
Websitehttp://www.esperion.com
Company Executives
- Name
- Position
- Salary
- Sheldon L. Koenig
- Director, President and Chief Executive Officer
- 2.97M
- Benjamin Halladay
- Chief Financial Officer and Principal Accounting Officer
- --
- Eric Warren, R.Ph.
- Chief Commercial Officer
- 1.08M
- J. Martin Carroll
- Chairman of the Board
- 117.28K
- Tracy M. Woody
- Independent Director
- 91.97K
- Seth H.Z. Fischer
- Independent Director
- 99.78K
- Jay P. Shepard
- Independent Director
- 97.28K
- Alan Fuhrman
- Independent Director
- 104.78K
- Dr. Antonio M. Gotto,Jr,M.D.,D.Phil.
- Independent Director
- 82.28K
- Stephen C. Rocamboli
- Independent Director
- 94.78K
- Nicole Vitullo
- Independent Director
- 94.78K
- Benjamin O. Looker
- General Counsel
- --
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.